companies

Selected for coverage on EMBASE

Epigenomics, Imaging in Medicine and Interventional Cardiology selected for coverage on EMBASE

We are pleased to announce that Epigenomics, Imaging in Medicine and Interventional Cardiology have been selected for coverage on EMBASE.

EMBASE is the most comprehensive online source of biomedical answers. With over 20 million records from more than 7,000 active authoritative journals, EMBASE delivers comprehensive, authoritative, reliable coverage of the most relevant biomedical literature.

Epigenomics, Imaging in Medicine and Interventional Cardiology are published bi-monthly in print and online formats on a rapid publication basis, with articles subject to peer review by at least three independent assessors. These titles have international expert authorship and offer review articles, drug profiles, editorials, technology reports, interviews, perspectives and a variety of added-value content.

For more information on any of these titles please visit our Future Medicine website.

Link to this page from